Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Seyitler Kimyanayi ASIST:SEYKM -2.47%62 EV-to-EBITDA is 10.46 as of Sep. 03, 2026, which is 6% below its 10-year median of 11.11. GuruFocus rates IST:SEYKM with a GF Score™ of 62/100 and a GF Value™ of ₺2.70 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 514 Medical Devices & Instruments companies, Seyitler Kimyanayi AS ranks better than 63.62% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Seyitler Kimyanayi AS's enterprise value is ₺598.0 Mil.
Seyitler Kimyanayi AS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₺57.2 Mil. Therefore, Seyitler Kimyanayi AS's EV-to-EBITDA for today is 10.46.
The historical rank and industry rank for Seyitler Kimyanayi AS's EV-to-EBITDA or its related term are showing as below:
IST:SEYKM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -368.09 Med: 11.11 Max: 134.8
Current: 10.46
During the past 12 years, the highest EV-to-EBITDA of Seyitler Kimyanayi AS was 134.80. The lowest was -368.09. And the median was 11.11.
IST:SEYKM's EV-to-EBITDA is ranked better than 63.62% of 514
companies
in the Medical Devices & Instruments industry
Industry Median: 14.355
vs IST:SEYKM: 10.46
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Seyitler Kimyanayi AS (IST:SEYKM) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Seyitler Kimyanayi AS's PE Ratio (TTM) for today is calculated as:
Seyitler Kimyanayi AS's share price for today is ₺4.34.
Seyitler Kimyanayi AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺0.140.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Seyitler Kimyanayi AS EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Seyitler Kimyanayi AS's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IST:SEYKM vs ISRG, BDX, RMD: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Seyitler Kimyanayi AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seyitler Kimyanayi AS EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Seyitler Kimyanayi AS's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Seyitler Kimyanayi AS's EV-to-EBITDA falls into.
Seyitler Kimyanayi AS's current Enterprise Value is ₺598.0 Mil.
Seyitler Kimyanayi AS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺57.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seyitler Kimyanayi AS (IST:SEYKM) has a EV-to-EBITDA of 10.46 as of Sep. 03, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Seyitler Kimyanayi AS. This is near median its historical median of 11.11. According to the industry distribution chart, Seyitler Kimyanayi AS ranks #187 out of 514 companies in the Medical Devices & Instruments industry, placing it in the top 36.4%.
Is Seyitler Kimyanayi AS's EV-to-EBITDA too high?
Seyitler Kimyanayi AS's current EV-to-EBITDA of 10.46 is near median its 10-year median of 11.11. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.36. Seyitler Kimyanayi AS's value of 10.46 is 27.1% below this industry median. Based on the distribution chart, Seyitler Kimyanayi AS ranks #187 out of 514 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Seyitler Kimyanayi AS has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Seyitler Kimyanayi AS's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Seyitler Kimyanayi AS ranks #187 out of 514 companies for EV-to-EBITDA. This puts Seyitler Kimyanayi AS in the upper half of its industry. The industry median EV-to-EBITDA is 14.36. Seyitler Kimyanayi AS's value of 10.46 is 27.1% below this benchmark. While the company's 10-year median is 11.11 vs. the industry median of 14.36, Seyitler Kimyanayi AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.36, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seyitler Kimyanayi AS's current EV-to-EBITDA of 10.46 is 27.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Seyitler Kimyanayi AS. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seyitler Kimyanayi AS's current EV-to-EBITDA is 10.46, which is near median its own 10-year median of 11.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seyitler Kimyanayi AS stock overvalued right now?
Based on GuruFocus' analysis, Seyitler Kimyanayi AS (IST:SEYKM) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺2.70, compared to a current price of ₺4.34 — trading 60.7% above its estimated fair value. The current EV-to-EBITDA is 10.46, which is near median its 10-year median of 11.11 and 27.1% below the Medical Devices & Instruments industry median of 14.36. Seyitler Kimyanayi AS's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Seyitler Kimyanayi AS (IST:SEYKM), the current EV-to-EBITDA is 10.46 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Seyitler Kimyanayi AS (IST:SEYKM) Overvalued in 2026?
Based on GuruFocus' analysis, Seyitler Kimyanayi AS stock appears to be overvalued.
The current stock price of ₺4.34 is trading 60.7% above its estimated GF Value™ of ₺2.70.
GuruFocus considers Seyitler Kimyanayi AS to be Significantly Overvalued.
Key valuation signals for IST:SEYKM:
EV-to-EBITDA: 10.46 (near median its 10-year median of 11.11)
GF Value™: ₺2.70 vs. price of ₺4.34 (60.7% above fair value)
Industry Position: 27.1% below the Medical Devices & Instruments median (#187 of 514)
No single metric tells the full story. See the IST:SEYKM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Seyitler Kimya Sanayi AS is engaged in manufacturing Medical plaster, first aid plaster, and capsicum perforated rheumatism plaster. Its products include Medical Tapes, Medical fluids, Wound Dressing, First-Aid plaster and Eye products among others.
62GF Score
Get the complete analysis for IST:SEYKM
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SEYKM has been successfully added to your 
